Skip to main content

Table 1 Sample demographic and clinical characteristics, overall and by retention in care status

From: Barriers and facilitators to patient retention in HIV care

Characteristica Total Retained in careh Not retained in careh
(N = 51) (N = 25) (N = 26)
Age (years)b
18-29 4 (8 %) 1 (4 %) 3 (12 %)
30-39 11 (22 %) 2 (8 %) 9 (35 %)
40-49 18 (35 %) 10 (40 %) 8 (31 %)
≥50 18 (35 %) 12 (48 %) 6 (23 %)
Sex
Male 27 (53 %) 19 (76 %) 8 (31 %)
Female 24 (47 %) 6 (24 %) 18 (69 %)
Race/Ethnicity
White 6 (12 %) 3 (12 %) 3 (12 %)
Black 41 (80 %) 21 (84 %) 20 (77 %)
Hispanic 3 (6 %) 1 (4 %) 2 (8 %)
Other 1 (2 %) 0 (0 %) 1 (4 %)
HIV risk factorc
MSM 13 (26 %) 8 (32 %) 5 (19 %)
Heterosexual 35 (69 %) 14 (56 %) 21 (81 %)
IDU 3 (6 %) 3 (12 %) 0 (0 %)
Insuranced
Private 4 (8 %) 1 (4 %) 3 (12 %)
Medicaid 34 (67 %) 17 (68 %) 17 (65 %)
Medicare 10 (18 %) 6 (24 %) 4 (15 %)
Uninsured 3 (6 %) 1 (4 %) 2 (8 %)
ART regimene
PI 29 (57 %) 16 (64 %) 13 (50 %)
NNRTI 15 (29 %) 7 (28 %) 8 (31 %)
Integrase 5 (10 %) 2 (8 %) 3 (12 %)
Not on ART 2 (4 %) 0 (0 %) 2 (8 %)
CD4 cell count (cell/mm3)f
≤ 200 8 (16 %) 6 (24 %) 2 (8 %)
201-350 8 (16 %) 2 (8 %) 6 (23 %)
351-500 8 (16 %) 4 (16 %) 4 (15 %)
> 500 27 (53 %) 13 (52 %) 14 (54 %)
Viral suppressiong
Suppressed 29 (57 %) 17 (68 %) 12 (46 %)
Not suppressed 22 (43 %) 8 (32 %) 14 (54 %)
  1. Abbreviations: ART antiretroviral therapy, MSM men who have sex with men, IDU injection drug use, PI protease inhibitor, NNRTI non-nucleoside reverse transcriptase inhibitor
  2. aCharacteristics and values within the 12-month period prior to interview date
  3. bAge on the date of interview
  4. cPatients who had IDU in combination with another risk factor (e.g. MSM, HET) were classified as IDU
  5. dPatients with both Medicare and Medicaid were grouped as Medicare
  6. ePatients were considered to be on ART if they concomitantly received ≥ 3 antiretroviral drugs (excluding ritonavir) during the 12-month period prior to the interview date. ART regimen prescribed closest to the interview date was grouped using the following hierarchy: (1) PI-based; (2) NNRTI-based; and (3) integrase inhibitor-based
  7. fCD4 cell count closest to the date of interview
  8. gHIV viral suppression was categorized as suppressed (HIV-1 RNA ≤ 400 copies/mL) and not suppressed (HIV-1 RNA > 400 copies/mL) based on the median value in the 12-month period before the interview date
  9. hRetention in care was defined as completing 2 or more primary HIV care visits separated by ≥ 90 days in the 12-month period prior to the interview date